Objectives
Several recent studies have suggested that the physiopathology of bipolar disorder (BD) is related to immune system alterations and inflammation. Lithium (Li) is a mood stabilizer that is considered the first‐line treatment for this mood disorder. The goal of the present study was to investigate the effects of Li administration on behavior and cytokine levels [interleukin (IL)‐1β, IL‐4, IL‐6, IL‐10, and tumor necrosis factor‐alpha (TNF‐α)] in the periphery and brains of rats subjected to an animal model of mania induced by amphetamine (d‐AMPH).
Methods
Male Wistar rats were treated with d‐AMPH or saline (Sal) for 14 days; on Day 8 of treatment, the rats were administered Li or Sal for the final seven days. Cytokine (IL‐1β, IL‐4, IL‐6, IL‐10, and TNF‐α) levels were evaluated in the cerebrospinal fluid (CSF), serum, frontal cortex, striatum, and hippocampus.
Results
The present study showed that d‐AMPH induced hyperactivity in rats (p < 0.001), and Li treatment reversed this behavioral alteration (p < 0.001). In addition, d‐AMPH increased the levels of IL‐4, IL‐6, IL‐10, and TNF‐α in the frontal cortex (p < 0.001), striatum (p < 0.001), and serum (p < 0.001), and treatment with Li reversed these cytokine alterations (p < 0.001).
Conclusions
Li modulates peripheral and cerebral cytokine production in an animal model of mania induced by d‐AMPH, suggesting that its action on the inflammatory system may contribute to its therapeutic efficacy.